Mr Mrs Miss Ms Dr Other

Mr
Craig
Thomson

Partner & Patent Attorney

Glasgow Office Aberdeen Office Westport Office Dublin Office

Life sciences

Telephone. +44(0) 141 229 5800
Mobile. +44(0) 798 808 8054
Email. [email protected]
Vcard
Linkedin

Experience

Craig is recognised for providing pragmatic, commercially focused advice to clients in the biotechnological, pharmaceutical, chemical and MedTech sectors. As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, funding/acquisition due-diligence, and aggressive/defensive strategies in relation to third-party IP.

Having worked closely with multi-national corporations, Craig understands the challenges associated with efficiently prosecuting large multi-national patent portfolios, whilst keeping them relevant to the business. He values this experience as it helps him to provide expert guidance to SMEs as they grow or prepare for acquisition.
Whilst part of Craig’s focus is ensuring that technical aspects of each invention is accurately captured in a patent, he understands that the value of IP can only be fully realised after understanding the commercial goals of a business, and how IP can best be exploited to help underpin those goals. It is therefore important for him to understand more generally his client’s business; enabling him to provide them with a more broad-ranging, effective and valuable set of solutions. Industry sectors for which Craig has considerable knowledge of include those concerned with the microbiome, food, formulations, anti-infectives, diagnostics and MedTech.

Craig has a proven track record of providing successful outcomes for clients, both in a wide-range of legal proceedings (including opposition, entitlement, and USPTO interviews) and in successful IP-license/assignment deals involving patents that he both drafted and prosecuted to grant. He has co-written an amicus curiae (filed with the US Supreme Court for Sequenom v Ariosa), and has assisted many clients to successfully obtain investment, including listing on AIM.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe
Ireland

BSC

Physiology and Pharmacology

MSC

Management of Intellectual Property

Recognition

IAM Patent 1000: The World’s Leading Patent Professionals 2020

“Craig Thomson, who is well versed in all things biotechnological and pharmaceutical, particularly therapeutic and diagnostic inventions. He has a “phenomenal ability to quickly grasp the key concepts in an invention and tease out the most inventive aspects so as to file the strongest possible patents. He is always on hand to guide patent strategy and has incredible patience when explaining the intricacies of the prosecution process. He is also ridiculously good fun to work with!” “He takes a practical, business-oriented approach, focusing on what will drive value in the European market in a way that enables informed decision making. In view of technological convergence, his technical versatility is invaluable.””

View recognition online

IAM Patent 1000: The World’s Leading Patent Professionals 2019

“Taking the reins on this initiative is Craig Thomson, an experienced handler of biotech, pharmaceutical, chemical and medical innovations. Thomson is a seasoned prosecutor and serves up trenchant advice on IP strategy in connection with technology-driven deals and enforcement issues; the broad ambit of his practice has helped him develop a refined commercial sense.”

Publications

Managing Intellectual Property IP Stars 2023

View publication online

HGF continues to grow across Europe with office relocation and expansion in the Island of Ireland

View publication online

IAM Patent 1000 2022

View publication online

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

View publication online

KTN Microbiome Strategic Roadmap

View publication online

IAM Patent 1000 2020

View publication online

The Vedanta Opposition: A healthy sign of a maturing industry

View publication online

IAM Patent 1000 2019

View publication online

The Vedanta Opposition: A healthy sign of a maturing industry

Download publication PDF

Securing Commercial Advantage Through Innovations in Microbiome Therapeutic Production

View publication online

Download publication PDF

Validity Attack on US Patent for Bifidobacetrium ComboTherapy: What can we learn?

View publication online

Download publication PDF

LSIPR: Will Big Pharma Get The Bug For Microbiome Therapies?

View publication online

Conferences: 2022

October 22nd 2022

BIONABU Health Entrepreneurship and Innovation Summit 2022

Speaker

Event details

Conferences: 2021

October 26th 2021

9th Microbiome R&D and Business Collaboration Forum: Europe

Speaker

Event details

October 21st 2021

Medical Technology Ireland Conference 2021

Speaker

Event details

October 4th 2021

IPBC Europe 2021

Speaker

Event details

March 24th 2021

Animal Microbiome Conference 2021

Speaker

March 3rd 2021

Animal Microbiome Congress 2021

Speaker

Event details

January 27th 2021

IAM webinar: Preparing for the IP due diligence checklist of the future for microbiome innovation

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Conferences: 2020

October 15th 2020

4th Microbiome: Recent Developments, Regulatory, Quality and Commercialization Summit

Speaker

Event details

October 15th 2020

Microbiome Movement - Maternal & Infant Health Summit 2020

Speaker

Event details

September 8th 2020

Sustainable Protein Production and Animal Microbiome Virtual Summit 2020

Speaker

Event details

September 1st 2020

ONE Life Sciences Leadership Forum 6

Speaker

Event details

July 8th 2020

Webinar: Attracting big pharma to the Microbiome field

Speaker

Event details

April 24th 2020

Translational Microbiome Conference 2020

Speaker

Event details

Conferences: 2019

September 26th 2019

Medical Technology Ireland - Galway Racecourse

Speaker

Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

CSR

Craig provides the annual lecture, “Capturing, Protecting and Exploiting Intellectual Property in Business”, on the Masters Course for “Management of Innovation and Creativity” at Glasgow Caledonian University.

As IP lead, Craig is part of the Microbiome Innovation Network, part of the KTN, whos aims are to accelerate the commercialisation of microbiome-based products and services in the UK and create a vibrant community by connecting industry and academia. Craig also wrote the IP section for the Networks Roadmap document for the industry (https://ktn-uk.org/agrifood/microbiome/).

Related News

Managing Intellectual Property IP Stars 2023

After months of research, Managing IP has published the IP Stars list for 2023. HGF is delighted to have 23 attorneys from England, Scotland, Ireland, Netherlands and Germany recognised and …

Read article

Profiting from Innovation Within Product Platforms

Innovative businesses should seek to maximise the value they obtain from working collaboratively within a product platform ecosystem. A well-defined IP strategy can help achieve this while increasing total innovation …

Read article
Event - 25th May 2023

New seminar series in Salzburg, Dresden and Hamburg

HGF is organising a new German-speaking seminar series in Salzburg, Dresden, and Hamburg starting May 25 2023. Dates May 25, 2023 at 17:30 – Salzburg June 1 2023 at 17:30 …

Event details

Can Artificial Intelligence save the NHS?

In recent months, it has been almost impossible to escape reports of the staffing crisis in the NHS and the impact this is having on the services the NHS can …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us